Navigation Links
Cervical Cancer Screening Market Worth $22 Billion by 2020
Date:3/20/2015

DALLAS, March 20, 2015 /PRNewswire/ --

According to a new market research report " The Cervical Cancer Screening Market by Test Type (PAP, HPV), Kit Type (PAP, HPV), End User (Hospitals, Laboratories, Physicians' Offices & Clinics) -Global Forecast to 2020", published by MarketsandMarkets, The Cervical Cancer Screening Market is expected to reach around $22 Billion by 2020 with a CAGR of 7% during the forecast period (2015 to 2020).

Browse 61 market data tables and 24 figures spread through 200 pages and in-depth TOC on "Cervical Cancer Screening Market"

http://www.marketsandmarkets.com/Market-Reports/cervical-cancer-screening-market-10110147.html

Early buyers will receive 10% customization on this report. 

The Cervical Cancer Screening Market is poised to reach ~$22 Billion by 2020 from ~$15 Billion in 2014, at an estimated CAGR of 7.0% from 2015 to 2020. Factors such as rising prevalence of cervical cancer and favorable government initiatives and funding to increase disease awareness are driving the Global cervical cancer screening market. However, the availability of HPV vaccines, uncertain reimbursement rates, and changes in regulatory guidelines are hindering the growth of this market.

Inquiry before Buying:  http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=10110147

The Cervical Cancer Screening Market is segmented on the basis of test types, end users, and geographies. Based on test type, the cervical cancer screening market is segmented into pap tests and HPV/co tests. Among both, the HPV/co-test is estimated to grow at a higher CAGR during the forecast period. This growth can largely be attributed to the growing incidences of cervical cancer, higher consistency and effectiveness of HPV tests and co-tests that reduce the annual cost of the treatment and changing regulatory guidelines in favor of HPV tests.

On the basis end users, the Cervical Cancer Screening market is classified into hospitals, laboratories, and independent physicians' offices and clinics. The laboratories segment accounted for the largest share in 2014, while the hospitals segment is estimated to grow at a faster rate due to the increasing volume of patients in hospitals.

On the basis of geography, the Cervical Cancer Screening Market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). In 2014, North America accounted for the largest share of the cervical cancer screening market, followed by Europe. Both these markets are estimated to register single-digit growth rates over the next five years. However, Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region. Growth of the cervical cancer screening market in the Asia-Pacific region will revolve around China, India, Australia, and countries in the Middle East.

The key players in the Cervical Cancer Screening Tests and Kits Market are Hologic (U.S.), Qiagen N.V. (Netherlands), Becton, Dickinson and Company (U.S.), and Hoffman-La Roche (Switzerland).

Browse Related Reports: 

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018

http://www.marketsandmarkets.com/Market-Reports/cancer-tumor-profiling-market-1250.html

About MarketsandMarkets

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain  @  http://www.marketsandmarkets.com/Subscription.html

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices 

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
E-mail: sales@marketsandmarkets.com


'/>"/>
SOURCE MarketsandMarkets
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury
2. Simplify Medical Announces CE Mark for New MRI Compatible Cervical Artificial Disc
3. Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery
4. Asterias Biotherapeutics Receives U.S. FDA Clearance to Initiate Phase 1/2a Clinical Trial of AST-OPC1 in Patients with Cervical Complete Spinal Cord Injury
5. Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer
6. Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
7. CEO Dr. Joseph Kim to Discuss Inovios Innovative Approach to Treating Cervical Cancer in an Expert Panel
8. Cepheid Highlights Promising Early Performance Of Its Cervical Cancer Test At AMP
9. Neck Pain From Cervical Herniated Disc: Simply Try Traction
10. University of Virginia Cancer Center Begins Using New Telemedicine Technology for Cervical Cancer Screenings
11. ASCO Impact Report from Encuity Research Indicates Strong Interest in New Treatments for Melanoma and Cervical Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... Fix Inc. (" Fortuna "), a private, clinical-stage biotech ... need for embryonic and fetal stem cells by using direct ... Fortuna announced today the launch of its Scientific ... PhD; Father Kevin FitzGerald , S.J., PhD; Col. (R) ... Giordano , PhD. "We are excited and honored ...
(Date:5/4/2017)... , May 4, 2017  DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... Company, and STI Technologies Limited to lower diabetes healthcare ... Through STI,s innoviCares card, which is available throughout all ... DarioHealth customers will be eligible for additional savings when ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... ... Axiad IDS , a leading provider of trusted identities for enterprise, ... a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor in ... address potential cybersecurity threats before they happen. The annual list of top ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... the pharmaceutical and medical device sectors, today announced the winners of its 3rd ... Entrepreneurs) represent the most influential people in the healthcare industry today. , Out ...
(Date:5/23/2017)... ... May 23, 2017 , ... New England Journal Of Medicine Confirms Viability of ... Response”, -The Rory Staunton Foundation Calls on Health & Human Services, Tom Price to ... ( http://www.rorystauntonfoundation.org ) today reported on a new study released on May 21, 2017 ...
(Date:5/23/2017)... ... May 23, 2017 , ... The National ... is pleased to announce the organization’s Certified Strength Coach credential has earned accreditation ... Coach (CSC) program validates the competency of qualified candidates for jobs in the ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... Reconstructive Surgeon Dr. Kevin Sadati, is pleased to announce a new treatment option ... and elastin in their face, neck, and body through a virtually pain-free, non-surgical ...
Breaking Medicine News(10 mins):